
Silexion Therapeutics Ltd.
SLXNHealthcare|Biotechnology|IL
$0.15
+0.00 (+0.97%)
DCF Value
$35.88
Tangible Book / Share
$0.06
Cash / Share
$3.24
Next Earnings Report
Nov 11, 2026
EPS est. -$9.10
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Oct 28, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Sep 30, 2026 · GlobeNewsWire
Silexion Therapeutics Announces Exercise of Warrants
Sep 29, 2026 · GlobeNewsWire
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
Sep 28, 2026 · GlobeNewsWire
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
Sep 9, 2026 · GlobeNewsWire
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026 · GlobeNewsWire
Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
Aug 11, 2026 · GlobeNewsWire
SEC Filings (195)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 28, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 26, 2026 | 8-K | Material event | DocumentIndex |
| Oct 19, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Oct 5, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Sep 30, 2026 | 8-K | Material event | DocumentIndex |
| Sep 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Sep 28, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 28, 2026 | 8-K | Material event | DocumentIndex |
| Sep 25, 2026 | 8-K | Material event | DocumentIndex |
| Sep 25, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Sep 25, 2026 | 8-K | Material event | DocumentIndex |
| Sep 16, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 9, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 24, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 21, 2026 | 8-K | Material event | DocumentIndex |
| Aug 19, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 18, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 11, 2026 | EFFECT | DocumentIndex | |
| Aug 10, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Aug 10, 2026 | 8-K | Material event | DocumentIndex |
| Aug 7, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Aug 4, 2026 | 8-K | Material event | DocumentIndex |
| Aug 3, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 29, 2026 | 8-K | Material event | DocumentIndex |
| Jul 21, 2026 | 8-K | Material event | DocumentIndex |
| Jul 13, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 23, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 18, 2026 | EFFECT | DocumentIndex | |
| Jun 18, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jun 16, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 12, 2026 | S-3 | Shelf registration | DocumentIndex |